Result of AGM

RNS Number : 7589H
Dechra Pharmaceuticals PLC
07 November 2008
 




Issued by Citigate Dewe Rogerson Limited, Birmingham

Date: 7 November 2008


Dechra® Pharmaceuticals PLC

(the 'Company' or the 'Group')

Results of Annual General Meeting ('AGM')



Dechra Pharmaceuticals PLC announces that all resolutions proposed at its AGM held on 7 November 2008 were duly passed on a show of hands.


Copies of the following:


  • Ordinary resolution adopting the Dechra Long Term Incentive Plan 2008;


  • Ordinary resolution approving the amendments to the Dechra Pharmaceuticals Approved Share Option Scheme;


  • Ordinary resolution approving the amendments to the Dechra Pharmaceuticals Unapproved Share Option Scheme;


  • Ordinary resolution relating to the renewal of the authority for the directors to allot new shares;


  • Special resolution relating to the renewal of the authority for the directors to disapply pre-emption rights;


  • Special resolution relating to the renewal of the authority for the Company to purchase its own shares; and


  • Special resolution relating to the adoption of new Articles of Association,


being resolutions (other than resolutions concerning ordinary business) passed by the Company at its AGM on 7 November 2008will be submitted to the UK Listing Authority and will thereafter be available for publication at the UK Listing Authority's Document Viewing Facility which is situated at :


    Financial Services Authority

    25 The North Colonnade

    Canary Wharf

    London E14 5HS


    Tel : 020 7066 1000

  

Details of the proxy voting instructions lodged prior to the AGM are set out below:


Resolution (No. as noted on proxy form)


For

Against

Discretionary

Withheld

Resolution 1:

To receive and consider report and accounts


40,583,352

0

12,918

208

Resolution 2:

To receive and approve the Directors Remuneration Report


39,533,536

733,072

12,918

316,952

Resolution 3:

To declare a final dividend


40,583,352

0

12,918

208

Resolution 4:

To re-elect Ian Page


40,555,971

27,589

12,918

0


Resolution 5:

To re-elect Neil Warner


40,434,449

148,903

12,918

208


Resolution 6:

To re-appoint KPMG Audit plc as Auditors and to authorise the directors to fix their remuneration


40,293,715

289,845

12,918

0

Resolution 7:

To approve the adoption of the LTIP


39,430,332

1,153,020

12,918

208

Resolution 8:

To approve the

amendments to the Dechra

Pharmaceuticals PLC

Approved Share Option

Scheme

40,476,190

18,550

13,070

88,668

Resolution 9:

To approve the amendments to the Dechra Pharmaceuticals PLC Unapproved Share Option Scheme


40,476,190

18,550

13,070

88,668

Resolution 10:

To grant authority to allot equity securities


40,581,578

1,830

13,070

0


Resolution 11:

To renew authority for pre-emptive allotment of equity securities


40,579,698

3,294

13,278

208

Resolution 12:

To grant authority to the Company to purchase ordinary shares


40,581,034

2,318

12,918

208

Resolution 13:

To adopt New Articles of 

Association

40,581,522

1,830

12,918

208



Enquiries:
 
 
Zoe Bamford, Company Secretary
Dechra Pharmaceuticals PLC
Tel: +44 (0) 1782 771100


Dechra and the Dechra 'D' logo are registered Trademarks of Dechra Pharmaceuticals PLC


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGEAKFXELKPFFE
UK 100

Latest directors dealings